Circulating free DNA as a diagnostic marker for echinococcosis: a systematic review and meta-analysis
- PMID: 39021627
- PMCID: PMC11251952
- DOI: 10.3389/fmicb.2024.1413532
Circulating free DNA as a diagnostic marker for echinococcosis: a systematic review and meta-analysis
Abstract
Introduction: Echinococcosis is a chronic zoonotic disease caused by tapeworms of the genus Echinococcus. The World Health Organization (WHO) has identified encapsulated disease as one of 17 neglected diseases to be controlled or eliminated by 2050. There is no accurate, early, non-invasive molecular diagnostic method to detect echinococcosis. The feasibility of circulating free DNA as a diagnostic method for echinococcosis has yielded inconclusive results in a number of published studies. However, there has been no systematic evaluation to date assessing the overall performance of these assays. We report here the first meta-analysis assessing the diagnostic accuracy of cfDNA in plasma, serum, and urine for echinococcosis.
Methods: We systematically searched PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure (CNKI), and WeiPu databases up to 17 January 2024, for relevant studies. All analyses were performed using RevMan 5.3, Meta-DiSc 1.4, Stata 17.0, and R 4.3.1 software. The sensitivity, specificity, and other accuracy indicators of circulating free DNA for the diagnosis of echinococcosis were summarized. Subgroup analyses and meta-regression were performed to identify sources of heterogeneity.
Results: A total of 7 studies included 218 patients with echinococcosis and 214 controls (156 healthy controls, 32 other disease controls (non-hydatid patients), and 26 non-study-targeted echinococcosis controls were included). Summary estimates of the diagnostic accuracy of cfDNA in the diagnosis of echinococcosis were as follows: sensitivity (SEN) of 0.51 (95% CI: 0.45-0.56); specificity (SPE) of 0.99 (95% CI: 0.97-0.99); positive likelihood ratio (PLR) of 11.82 (95% CI: 6.74-20.74); negative likelihood ratio (NLR) of 0.57 (95% CI: 0.41-0.80); diagnostic ratio (DOR) of 36.63 (95% CI: 13.75-97.59); and area under the curve (AUC) value of 0.98 (95% CI: 0.96-1.00).
Conclusion: Existing evidence indicates that the combined specificity of circulating cfDNA for echinococcosis is high. However, the combined sensitivity performance is unsatisfactory due to significant inter-study heterogeneity. To strengthen the validity and accuracy of our findings, further large-scale prospective studies are required.Systematic review registrationThe systematic review was registered in the International Prospective Register of Systematic Reviews PROSPERO [CRD42023454158]. https://www.crd.york.ac.uk/PROSPERO/.
Keywords: circulating free DNA; diagnostic marker; echinococcosis; meta-analysis; systematic review.
Copyright © 2024 Luo, Jiang, Ma, Li, Zhou, Wei, A, Chai, Lv, Cheng, Cao and A.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures










Similar articles
-
Diagnostic value of circulating cell-free DNA for renal cell carcinoma: a meta-analysis.Transl Cancer Res. 2021 May;10(5):2265-2276. doi: 10.21037/tcr-20-3448. Transl Cancer Res. 2021. PMID: 35116544 Free PMC article.
-
Circulating cell free DNA as the diagnostic marker for colorectal cancer: a systematic review and meta-analysis.Oncotarget. 2018 May 11;9(36):24514-24524. doi: 10.18632/oncotarget.25314. eCollection 2018 May 11. Oncotarget. 2018. PMID: 29849957 Free PMC article.
-
MicroRNA panels as diagnostic biomarkers for colorectal cancer: A systematic review and meta-analysis.Front Med (Lausanne). 2022 Nov 7;9:915226. doi: 10.3389/fmed.2022.915226. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36419785 Free PMC article.
-
Diagnostic accuracy of circulating miRNAs to discriminate hepatocellular carcinoma from liver cirrhosis: a systematic review and meta-analysis.Front Med (Lausanne). 2024 Apr 24;11:1359414. doi: 10.3389/fmed.2024.1359414. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38721351 Free PMC article.
-
Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis.Front Immunol. 2024 Mar 8;15:1362437. doi: 10.3389/fimmu.2024.1362437. eCollection 2024. Front Immunol. 2024. PMID: 38524131 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources